This year, the US government issued a statement to invest $400 million a year to implement the National Microbiological Group (NMI), and with the help of several national agencies, will attempt to map and study these microbial combinations in the next two years. Together with the $1 billion investment in society each year, the US now has $1.4 billion in annual funding for microbiology research. Under the influence of the US investment research community, with the maturity of the second-generation gene sequencing technology, the cost has been greatly reduced. China's microbiological research related companies have also sprung up, and the focus of the intestines, which was established as early as 14 years ago. The quantitative health of the microbiome test has gained our attention because of its unique judgment and vision. "Graduation" from Huada, founded the company of individual microbiome genetic testing Quantitative Health is a biotechnology services company focused on microbial molecular testing and related applications. Based on the second-generation high-throughput sequencing system, the company has independently developed a series of detection technologies and tools for microbiome testing; through these unique detection technologies and tools, it provides microbial detection solutions for research and institutions or companies in the field of health. Quantitative health founder Zhao Baiwen has led a multi-million dollar research project. He was awarded "2013 Global 35 Outstanding Young Technology Innovators" under 35 years old. (MIT "Technology Business Review"), "2014 and 2015 Asian 40 under 40 business elites" ("Fortune"), and "30 Asian Under 30s" ("Forbes"). Quantitative Health Founder Zhao Baiwen At the age of 18, he joined Huada Gene as a high school student. In the case of being the most likely to become the fourth generation of Huada leaders, he left the "big boss" of China's genetic companies and decided to start his own business. Moreover, he did not engage in the direction of personal genome testing, but chose the direction of the microbiome that was rarely followed by the Chinese. In response to the departure of Huada’s entrepreneurship, Zhao Baiwen told reporters: “Hua Da is like my university. I studied there for 5 years. Although I can stay in school well, I will leave when I graduate. I want to go out to work. As for why I didn't choose personal genetic testing, it is like many college students will choose more promising when they are looking for a job. I am also the same. I think that individual microbiome genetic testing is more promising than personal genetic testing, so it is like this. Done." In 2015, the personal genetic testing market was 20 billion US dollars and grew at a compound annual growth rate of 10%. Zhao Baiwen told reporters that the future microbiome testing market will be as important as the personal testing market, even larger. Market size will exceed personal genetic testing Human health determines genetic and environmental factors by two factors. The difference between the former is reflected in the individual genome and can be measured by genomic technology. The latter difference is reflected in the individual microbiome and needs to be measured by metagenomic techniques. The individual microbiome is the interface between the human body and the environment. In other words, most environmental factors must pass through the symbiotic microbial group on the inner and outer surfaces (skin and mucous membrane) of the human body, including thousands of prokaryotes and a small number of single cells. Eukaryotes exert an influence on a pair of human bodies. Metabolism, the process by which the body exchanges energy and matter with the outside world, is continuously regulated by millions of functional genes contained in the symbiotic microbial group. The diversity of the symbiotic microbial group is much higher than that of the individual genome, and thus plays an important role in maintaining the homeostasis of the human body. Since the completion of the Human Genome Project (HGP) in 2001, intensive research on individual genomes has been uninterrupted for the past fifteen years, and related applications such as targeted therapies and non-invasive prenatal diagnosis have kept the individual genome industry more than 10% High-speed annual growth rate. Gauze Swabs 10X10,Premier Gauze Swabs,Vaseline Gauze Swab,Non Sterile Gauze Swabs Xinxiang Huaxi Sanitary Materials Co., Ltd. , https://www.huaximedical.com
Microbiome testing technology will revolutionize the five major medical industries
Next Article
J Gerontol: Can coffee inhibit dementia?